0001493152-23-041448.txt : 20231115 0001493152-23-041448.hdr.sgml : 20231115 20231115140821 ACCESSION NUMBER: 0001493152-23-041448 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231108 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kosasa Thomas CENTRAL INDEX KEY: 0001989846 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40386 FILM NUMBER: 231409983 MAIL ADDRESS: STREET 1: 1319 PUNAHOU STREET STREET 2: # 1040 CITY: HONOLULU STATE: HI ZIP: 96826 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OneMedNet Corp CENTRAL INDEX KEY: 0001849380 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 862076743 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TRIDENT COURT, 1 OAKCROFT ROAD STREET 2: CHESSINGTON CITY: SURREY STATE: X0 ZIP: KT9 1BD BUSINESS PHONE: 011-44-208-090-2009 MAIL ADDRESS: STREET 1: TRIDENT COURT, 1 OAKCROFT ROAD STREET 2: CHESSINGTON CITY: SURREY STATE: X0 ZIP: KT9 1BD FORMER COMPANY: FORMER CONFORMED NAME: Data Knights Acquisition Corp. DATE OF NAME CHANGE: 20210304 3 1 ownership.xml X0206 3 2023-11-08 0 0001849380 OneMedNet Corp ONMD 0001989846 Kosasa Thomas 6385 OLD SHADY OAK ROAD SUITE 250 EDEN PRAIRIE MN 55344 1 0 1 0 Common Stock 4952409 D Effective November 7, 2023, the newly appointed officers and directors of OneMedNet Corporation have entered into a Lock-Up Agreement for the Lock-Up Period commencing at Closing and end the earliest of: (a) six months from the Closing, and (b) the date after the Closing on which the Purchaser consummates a liquidation, merger, capital stock exchange, reorganization, or other similar transaction with an unaffiliated third party that results in all of the Purchaser's stockholders having the right to exchange their shares of the Purchaser Common Stock for cash, securities, or other property. Director /s/ Thomas Kosasa 2023-11-15 EX-24 2 ex-24.htm

Exhibit 24

POWER OF ATTORNEY

I, Thomas Kosasa, Director of OneMedNet Corporation (the “Company”), hereby authorize and designate Paul Casey as my agent and attorney-in-fact, with full power of substitution to: (1) prepare and sign on my behalf any Form 3, Form 4 or Form 5 under Section l6 of the Securities Exchange Act of 1934, as amended; (2) prepare and sign on my behalf any Form 144 Notice under the Securities Act of 1933, as amended, and file the same with the Securities and Exchange Commission; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended, or Section 5 of the Securities Act of 1933, as amended, or Rule 144 promulgated under such Act. This Power of Attorney shall remain in effect until the undersigned is no longer required to file Forms 3, 4, 5 and 144 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

Dated: November 15, 2023	Signed:	/s/ Thomas Kosasa
		Thomas Kosasa